American Conference
Institute (ACI) will be holding its next Paragraph IV Disputes conference on
December 4-5, 2012 in San Francisco, CA. 
The conference will allow attendees to:

• Navigate the
evolving case law surrounding obvious-type double patenting and formulate
litigation strategies based on prior art obviousness analysis;
• Examine method of
treatment claims in view of recent and pending decisions regarding inducement
of infringement and divided infringement;
• Comprehend the
impact of Therasense on the standard
for inequitable conduct and its implications for Hatch-Waxman cases;
• Evaluate new
trends in validity challenges including extended and delayed release
formulations; and
• Weigh the risks
and benefits of at-risk launches and assess potential damages.

In particular,
ACI's faculty will offer presentations on the following topics:

• Anticipating and
reassessing Paragraph IV challenges in the era of the patent cliff;
• Analyzing
invalidity & non-infringement assertions in light of the ANDA applicant's
pre-litigation obligations and assertions;
• Prior art
obviousness and obviousness-type double patenting: Legal analysis and practical
applications for brand names and generics;
• Labels, patents
and use codes: Understanding the significance of Novo Nordisk v. Caraco to Hatch-Waxman challenges;
• Reassessing
Paragraph IV strategies for method treatment patents in view of recent and
pending decisions regarding inducement and divided infringement;
• A view from the bench;
• FTC keynote:
Pay-for-delay update — to be presented by Markus H. Meier, Assistant Director,
Health Care Division Bureau of Competition, Federal Trade Commission;
• Settling
Paragraph IV disputes: Drafting and negotiation strategies for brand-names and
generics;
• Exclusivities and
forfeitures: New developments, controversies and concerns relative to Paragraph
IV litigation;
• Controversies
surrounding damages and injunctions relative to at risk launches; and
• Updating the
standards in inequitable conduct post-Therasense:
Ethical considerations for Paragraph IV cases.

In addition, two
pre-conference workshops will be offered on December 3, 2012.  The first, entitled "Hatch-Waxman and
BPCIA 101 — A Primer on IP Basics and regulatory Fundamentals" will take
place from 9:00 am to 12:30 pm, and the second, entitled "AIA/PTO Working
Group Session: Assessing The Impact of New PTO Procedures Under the AIA on
Paragraph IV Litigation" will take place from 2:00 pm to 5:30 pm.  A post-conference working group session
entitled "Biosimilars: Product Development Strategies, Regulatory Review,
and Anticipated Litigation Through A Hatch-Waxman Lens" will be offered
from 3:00 to 6:00 pm on December 5, 2012.

The agenda for the
Paragraph IV Disputes conference can be found here.  More information regarding the workshops and
master class can be found here.  A complete brochure for this conference,
including an agenda, detailed descriptions of conference sessions, list of
speakers, and registration form can be obtained here.

The registration
fee for the conference is $2,295 (conference alone), $2,895 (conference and one
workshop), $3,495 (conference and two workshops), or $4,095 (conference and all
workshops).  Those registering by October
5, 2012 will receive a $300 discount and those registering by November 2, 2012
will receive a $200 discount.  Patent
Docs readers who reference the discount code "PD
200" will receive $200 off the current price tier when registering.  Those
interested in registering for the conference can do so here, by
e-mailing CustomerService@AmericanConference.com, by calling 1-888-224-2480, or
by faxing a registration form to 1-877-927-1563.

Patent Docs is a media partner of the Paragraph IV Disputes conference.